EVARREST (Ethicon, Inc.)
Welcome to the PulseAid listing for the EVARREST drug offered from Ethicon, Inc.. This Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Ethicon, Inc. |
| NON-PROPRIETARY NAME: | Fibrinogen Human and Human Thrombin |
| SUBSTANCE NAME: | FIBRINOGEN HUMAN; HUMAN THROMBIN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | PATCH |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2013-03-01 |
| END MARKETING DATE: | 0000-00-00 |
EVARREST PLASMA DERIVATIVE Details:
| Item Description | EVARREST from Ethicon, Inc. |
| LABELER NAME: | Ethicon, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 8.6; 37.5(mg/cm2; [iU]/cm2) |
| START MARKETING DATE: | 2013-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63713-050_3a2e4b22-76e0-4406-8cd8-d67d595867a7 |
| PRODUCT NDC: | 63713-050 |
| APPLICATION NUMBER: | BLA125392 |
Other FIBRINOGEN HUMAN; HUMAN THROMBIN Pharmaceutical Manufacturers / Labelers:
